| Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease DS Goldstein, P Sullivan, C Holmes, GW Miller, S Alter, R Strong, ... Journal of neurochemistry 126 (5), 591-603, 2013 | 218 | 2013 |
| Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo KM Lohr, AI Bernstein, KA Stout, AR Dunn, CR Lazo, SP Alter, M Wang, ... Proceedings of the National Academy of Sciences 111 (27), 9977-9982, 2014 | 212 | 2014 |
| The N terminus of the adhesion G protein-coupled receptor GPR56 controls receptor signaling activity KJ Paavola, JR Stephenson, SL Ritter, SP Alter, RA Hall Journal of Biological Chemistry 286 (33), 28914-28921, 2011 | 203 | 2011 |
| Reduced vesicular storage of catecholamines causes progressive degeneration in the locus ceruleus TN Taylor, SP Alter, M Wang, DS Goldstein, GW Miller Neuropharmacology 76, 97-105, 2014 | 72 | 2014 |
| Targeting Protein Tyrosine Phosphatase SHP2 for the Treatment of PTPN11-Associated Malignancies B Yu, W Liu, WM Yu, ML Loh, S Alter, O Guvench, AD MacKerell Jr, ... Molecular cancer therapeutics 12 (9), 1738-1748, 2013 | 67 | 2013 |
| Vesicular integrity in Parkinson’s disease SP Alter, GM Lenzi, AI Bernstein, GW Miller Current neurology and neuroscience reports 13, 1-11, 2013 | 57 | 2013 |
| Selective enhancement of dopamine release in the ventral pallidum of methamphetamine-sensitized mice KA Stout, AR Dunn, KM Lohr, SP Alter, RA Cliburn, TS Guillot, GW Miller ACS chemical neuroscience 7 (10), 1364-1373, 2016 | 40 | 2016 |
| SHP-2 tyrosine phosphatase in human diseases H Zheng, S Alter, CK Qu International Journal of Clinical and Experimental Medicine 2 (1), 17, 2009 | 38 | 2009 |
| Reduced vesicular monoamine transport disrupts serotonin signaling but does not cause serotonergic degeneration SP Alter, KA Stout, KM Lohr, TN Taylor, KR Shepherd, M Wang, TS Guillot, ... Experimental neurology 275, 17-24, 2016 | 22 | 2016 |
| Reduced vesicular storage of catecholamines causes progressive degeneration in the locus ceruleus. Neuropharmacology 76 Pt A: 97–105 TN Taylor, SP Alter, M Wang, DS Goldstein, GW Miller | 9 | 2014 |
| Early postnatal exposure to ultrafine particulate matter air pollution: persistent ventriculomegaly, neurochemical disruption, and glial activation preferentially in male mice KM Lohr, AI Bernstein, KA Stout, AR Dunn, CR Lazo, SP Alter, M Wang, ... Environ Health Perspect 111 (27), 9977-9982, 2014 | 2 | 2014 |
| Impaired vesicular storage of norepinephrine and serotonin in Parkinson's disease-related pathogenesis SP Alter Emory University, 2015 | | 2015 |
| Progressive Noradrenergic Degeneration in Mice with Reduced Expression of the Vesicular Monoamine Transporter (VMAT2) SP Alter, TN Taylor, P Sullivan, DS Goldstein, GW Miller Catecholamine Research in the 21st Century, 125, 2014 | | 2014 |
| Proteomic analysis of tumor and adjacent non‐tumor intestinal tissue and tumor burden after iron supplementation in Apc Min/+ mice J Swain, S Alter, J Chang, H Zao, M Chance The FASEB Journal 22, 294.7-294.7, 2008 | | 2008 |
Randy A. HallProfessor of Pharmacology, Emory University School of MedicineDirección de correo verificada de emory.edu